Cart
sales@molnova.com
Lixisenatide acetate
CAS No. 1997361-87-1
Lixisenatide acetate( —— )
Catalog No. M30168 CAS No. 1997361-87-1
Lixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | In Stock |
|
| 10MG | 290 | In Stock |
|
| 25MG | 485 | In Stock |
|
| 50MG | 695 | In Stock |
|
| 100MG | 945 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
Biological Information
-
Product NameLixisenatide acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionLixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).
-
DescriptionLixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGLP-1 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1997361-87-1
-
Formula Weight5218.79
-
Molecular FormulaC215H347N61O65S.6C2H4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (9.58 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
7,2,4-Trihydroxy-5-m...
7,2',4'-Trihydroxy-5-methoxy-3-arylcoumarin shows activity in inhibiting prostate specific antigen (PSA) secreted from androgen dependent prostate cancer cell line, LNCaP cells.
-
CSP
CSP
-
Cyclosporin A-Deriva...
Cyclosporin A-Derivative 1 (Free base) is a crystalline intermediate derived from the opening of cyclosporin A extracted from patent WO 2013167703 A1.
